Clinical Trial Update: Multicenter Study of Patients With SHANK3 Mutations: Identification of Genes Modificators in Phelan-McDermid Syndrome (EUQ13) [NA]

View source ↗

Summary

A multicenter clinical trial investigating genetic modifiers in patients with SHANK3 mutations causing Phelan-McDermid syndrome; the study status is not yet rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phelan-mcdermid Syndrome

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Genetic Disease | NA | Status: NOT_YET_RECRUITING